Israel vs Singapore: Death rate from cancer
Israel
139.99 deaths per 100,000 people
in 2021
Singapore
138.32 deaths per 100,000 people
in 2021
Israel rank
70th
Singapore rank
72nd
Death rate from cancer over time
- Israel
- Singapore
How they compare
Israel currently reports 139.99 deaths per 100,000 people against 138.32 deaths per 100,000 people in Singapore, a difference of 1.67 deaths per 100,000 people.
Across all 22 years both countries report, Israel has been ahead every year.
Israel ranks 70th and Singapore ranks 72nd of 194 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Israel | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 151.63 deaths per 100,000 people | 113.58 deaths per 100,000 people | 38.04 deaths per 100,000 people | Israel |
| 2010s | 144.56 deaths per 100,000 people | 123.57 deaths per 100,000 people | 20.98 deaths per 100,000 people | Israel |
| 2020s | 139.9 deaths per 100,000 people | 136.3 deaths per 100,000 people | 3.6 deaths per 100,000 people | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Israel or Singapore?
- Israel, at 139.99 deaths per 100,000 people against 138.32 deaths per 100,000 people in Singapore as of 2021.
- What is the difference in death rate from cancer between Israel and Singapore?
- 1.67 deaths per 100,000 people, with Israel ahead.
- How many years of comparable data are there for Israel and Singapore?
- 22 years are reported by both, from 2000 to 2021.
- How do Israel and Singapore rank globally for death rate from cancer?
- Israel ranks 70th and Singapore ranks 72nd of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.